Literature DB >> 23513049

Left ventricular dysfunction with pulmonary hypertension: Part 1: epidemiology, pathophysiology, and definitions.

Vasiliki V Georgiopoulou1, Andreas P Kalogeropoulos, Barry A Borlaug, Mihai Gheorghiade, Javed Butler.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23513049     DOI： 10.1161/CIRCHEARTFAILURE.112.000095

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  12 in total

1.  Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers.

Authors:  Aaron W Trammell; Meredith E Pugh; John H Newman; Anna R Hemnes; Ivan M Robbins
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 2.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 3.  Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.

Authors:  Bhavadharini Ramu; Thenappan Thenappan
Journal:  Curr Heart Fail Rep       Date:  2016-04

4.  Time Dependence of the Effect of Right Ventricular Dysfunction on Clinical Outcomes After Myocardial Infarction: Role of Pulmonary Hypertension.

Authors:  Keren Shahar; Wisam Darawsha; Sergey Yalonetsky; Jonathan Lessick; Michael Kapeliovich; Robert Dragu; Diab Mutlak; Shimon Reisner; Yoram Agmon; Doron Aronson
Journal:  J Am Heart Assoc       Date:  2016-07-11       Impact factor: 5.501

5.  Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure.

Authors:  Fabio Luis de Jesus Soares; Janine Magalhães Garcia de Oliveira; Gabriel Neimann da Cunha Freire; Lucas Carvalho Andrade; Marcia Maria Noya-Rabelo; Luis Claudio Lemos Correia
Journal:  Arq Bras Cardiol       Date:  2017-11-27       Impact factor: 2.000

6.  Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection.

Authors:  Rebecca Scherzer; Sanjiv J Shah; Eric Secemsky; Javed Butler; Carl Grunfeld; Michael G Shlipak; Priscilla Y Hsue
Journal:  Circ Heart Fail       Date:  2018-04       Impact factor: 8.790

7.  Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction Patients.

Authors:  Hee Jin Kwon; Jae Hyeong Park; Jin Joo Park; Jae Hwan Lee; In Whan Seong
Journal:  J Cardiovasc Imaging       Date:  2019-10

8.  Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients.

Authors:  Andreas P Kalogeropoulos; Sarawut Siwamogsatham; Salim Hayek; Song Li; Anjan Deka; Catherine N Marti; Vasiliki V Georgiopoulou; Javed Butler
Journal:  J Am Heart Assoc       Date:  2014-02-03       Impact factor: 5.501

9.  Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS).

Authors:  Salman Waheed; Paulo H M Chaves; Julius M Gardin; Jie Jane Cao
Journal:  J Am Heart Assoc       Date:  2015-12-08       Impact factor: 5.501

Review 10.  Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rohan Samson; Abhishek Jaiswal; Pierre V Ennezat; Mark Cassidy; Thierry H Le Jemtel
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.